source
- Roche launches VENTANA BAP1 test to improve mesothelioma diagnosisRoche announced the global launch of its VENTANA BAP1 (SP527) test, an automated ready‑to‑use immunohistochemistry assay designed for differential diagnosis of mesothelioma. The assay targets the…
- Anthropic appoints former Genentech scientist Nathan Frey to lead drug discovery after acquiring Coefficient BioAnthropic, the AI company, recently bought biotech startup Coefficient Bio. Following the acquisition, the startup’s founder Nathan Frey, who previously worked at Genentech on machine‑learning proj…